Suppr超能文献

骨侵犯对口腔鳞状细胞癌下颌骨边缘性切除术后预后的影响。

Influence of bone invasion on outcomes after marginal mandibulectomy in squamous cell carcinoma of the oral cavity.

作者信息

Petrovic Ivana, Montero Pablo H, Migliacci Jocelyn C, Palmer Frank L, Ganly Ian, Patel Snehal G, Shah Jatin P

机构信息

Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, United States.

Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, United States.

出版信息

J Craniomaxillofac Surg. 2017 Feb;45(2):252-257. doi: 10.1016/j.jcms.2016.11.017. Epub 2016 Nov 30.

Abstract

INTRODUCTION

Marginal mandibulectomy (MM) is indicated for oral cavity squamous cell carcinomas (OCSCC) that abut or minimally erode the mandible without gross invasion. Successful implementation of MM is predicated on accurate patient selection and appropriate adjuvant treatment based on well-known host and tumor characteristics. The incidence of microscopically diagnosed bone involvement in MM specimens and its implications on outcomes have however not been reported in large contemporary series.

PURPOSE

To report the incidence of bone involvement and analyze its influence on oncologic outcomes in selected patients who underwent MM in treatment of OCSCC.

METHOD

A retrospective cohort study was performed on a consecutive series of previously untreated patients requiring MM, at a tertiary care cancer center, between 1985 and 2012 (n = 326). The median age was 64 years and 59% were male. The majority of patients (67%) had a primary tumor of the floor of the mouth or lower alveolus, 80% were clinically staged T1-2, and 31% were clinically N+. Postoperative radiation (PORT) was used in 27% and chemoradiation (POCTRT) in 8% of patients who had microscopic bone invasion. The median follow up period was 55 months and endpoints of interest were local and regional recurrence free (LRFS and RRFS) and disease specific (DSS) survival.

RESULTS

Microscopic bone invasion was present in 15% of patients (n = 49). Among these, cortical invasion was present in 32, medullary in 13, and it was not specified in 4. Eight patients had microscopic positive bone margins. Positive bone margins were associated with medullary bone involvement (p < 0.001), floor of mouth and buccal mucosa primary site (p = 0.03), and positive soft tissue margins (p = 0.06). LRFS and DSS were similar in patients without versus with bone invasion (62.8% vs 79.7% and 76.2% vs 66% respectively, p = NS). LRFS were similar in patients with microscopic positive versus negative bone margins, as long as postoperative adjuvant treatment was administered.

CONCLUSION

Microscopic bone involvement does not adversely influence outcomes but medullary bone involvement does confer a higher risk of positive bone margins. MM and appropriate adjuvant treatment is an effective strategy for treatment of OCSCC in selected patients with primary tumors adherent to or in proximity to the mandible.

摘要

引言

边缘性下颌骨切除术(MM)适用于紧邻或轻微侵蚀下颌骨但无明显侵犯的口腔鳞状细胞癌(OCSCC)。MM的成功实施取决于准确的患者选择以及基于众所周知的宿主和肿瘤特征进行适当的辅助治疗。然而,在当代大型系列研究中,尚未报道MM标本中显微镜下诊断的骨受累发生率及其对预后的影响。

目的

报告骨受累的发生率,并分析其对接受MM治疗OCSCC的选定患者肿瘤学预后的影响。

方法

对1985年至2012年期间在一家三级癌症中心接受MM治疗的一系列连续的未经治疗的患者进行回顾性队列研究(n = 326)。中位年龄为64岁,59%为男性。大多数患者(67%)原发肿瘤位于口底或下牙槽,80%临床分期为T1-2,31%临床N+。27%的患者接受了术后放疗(PORT),8%显微镜下有骨侵犯的患者接受了放化疗(POCTRT)。中位随访期为55个月,关注的终点为局部和区域无复发生存期(LRFS和RRFS)以及疾病特异性生存期(DSS)。

结果

15%的患者(n = 49)存在显微镜下骨侵犯。其中,32例有皮质侵犯,13例有髓质侵犯,4例未明确说明。8例患者显微镜下骨切缘阳性。骨切缘阳性与髓质骨受累(p < 0.001)、口底和颊黏膜原发部位(p = 0.03)以及软组织切缘阳性(p = 0.06)相关。无骨侵犯与有骨侵犯的患者的LRFS和DSS相似(分别为62.8%对79.7%和76.2%对66%,p = 无显著性差异)。只要进行了术后辅助治疗,显微镜下骨切缘阳性与阴性的患者的LRFS相似。

结论

显微镜下骨受累不会对预后产生不利影响,但髓质骨受累确实会增加骨切缘阳性的风险。MM及适当的辅助治疗是治疗选定的原发肿瘤紧贴或靠近下颌骨的OCSCC患者的有效策略。

相似文献

1
Influence of bone invasion on outcomes after marginal mandibulectomy in squamous cell carcinoma of the oral cavity.
J Craniomaxillofac Surg. 2017 Feb;45(2):252-257. doi: 10.1016/j.jcms.2016.11.017. Epub 2016 Nov 30.
4
Oncologic outcome of marginal mandibulectomy in squamous cell carcinoma of the lower gingiva.
BMC Cancer. 2019 Aug 6;19(1):775. doi: 10.1186/s12885-019-5999-0.
6
Marginal and segmental mandibulectomy in patients with oral cancer: a statistical analysis of 106 cases.
J Oral Maxillofac Surg. 2003 Nov;61(11):1289-96. doi: 10.1016/s0278-2391(03)00730-4.
7
Impact of mandibular invasion on prognosis in oral squamous cell carcinoma four centimeters or less in size.
Laryngoscope. 2017 Apr;127(4):849-854. doi: 10.1002/lary.26211. Epub 2016 Aug 2.
8
9
Marginal mandibulectomy: 11 years of institutional experience.
J Oral Maxillofac Surg. 2009 May;67(5):962-7. doi: 10.1016/j.joms.2008.08.019.
10
The prognostic impact of extent of bone invasion and extent of bone resection in oral carcinoma.
Laryngoscope. 2008 May;118(5):780-5. doi: 10.1097/MLG.0b013e31816422bb.

引用本文的文献

1
Role of Intraoperative Bone Dust Cytology for Assessing Bone Margins: A Novel Technique.
Indian J Surg Oncol. 2025 Feb;16(1):326-332. doi: 10.1007/s13193-024-02069-8. Epub 2024 Sep 18.
2
Prognosis, Controversies and Assessment of Bone Erosion or Invasion of Oral Squamous Cell Carcinoma.
Diagnostics (Basel). 2025 Jan 4;15(1):104. doi: 10.3390/diagnostics15010104.
3
Risk factors for local recurrence following marginal mandibulectomy in gingival cancer.
Sci Rep. 2024 Nov 1;14(1):26347. doi: 10.1038/s41598-024-77239-3.
5
Clinical, Radiological, and Pathological Correlation of Mandibular Invasion in Carcinoma Bucco-alveolar Complex.
Indian J Surg Oncol. 2024 Jun;15(2):385-396. doi: 10.1007/s13193-024-01903-3. Epub 2024 Feb 28.
7
Performance of Intraoperative Assessment of Resection Margins in Oral Cancer Surgery: A Review of Literature.
Front Oncol. 2021 Mar 30;11:628297. doi: 10.3389/fonc.2021.628297. eCollection 2021.
9
Oncologic outcome of marginal mandibulectomy in squamous cell carcinoma of the lower gingiva.
BMC Cancer. 2019 Aug 6;19(1):775. doi: 10.1186/s12885-019-5999-0.
10
Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery.
Clin Exp Otorhinolaryngol. 2019 May;12(2):107-144. doi: 10.21053/ceo.2018.01816. Epub 2019 Feb 2.

本文引用的文献

1
Prognosis for gingival carcinomas with a delayed diagnosis after dental extraction.
J Oral Maxillofac Surg. 2013 Dec;71(12):2189-94. doi: 10.1016/j.joms.2013.05.008. Epub 2013 Jul 17.
2
Current concepts in management of oral cancer--surgery.
Oral Oncol. 2009 Apr-May;45(4-5):394-401. doi: 10.1016/j.oraloncology.2008.05.017. Epub 2008 Jul 31.
3
Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas.
Crit Rev Oncol Hematol. 2005 Dec;56(3):353-64. doi: 10.1016/j.critrevonc.2005.04.010. Epub 2005 Jun 24.
5
The role of marginal mandibulectomy in the surgical management of oral cancer.
Arch Otolaryngol Head Neck Surg. 2002 May;128(5):604-5. doi: 10.1001/archotol.128.5.604.
6
Marginal mandibulectomy vs segmental mandibulectomy: indications and controversies.
Arch Otolaryngol Head Neck Surg. 2002 May;128(5):600-3. doi: 10.1001/archotol.128.5.600.
7
Oral squamous cell carcinoma of the mandibular region: A survival study.
Head Neck. 2001 Jul;23(7):536-43. doi: 10.1002/hed.1075.
8
Mandible preservation with oral cavity carcinoma: rim mandibulectomy versus sagittal mandibulectomy.
Am J Surg. 1993 Oct;166(4):411-5. doi: 10.1016/s0002-9610(05)80344-7.
10
Normal and pathologic CT anatomy of the mandible.
AJR Am J Roentgenol. 1982 Sep;139(3):555-9. doi: 10.2214/ajr.139.3.555.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验